Current Advisory Board Members
The ANZIC-RC is administered by an Advisory Board. The current ANZIC-RC Advisory Board Members are:
Professor (DJ) Jamie Cooper AO BMBS MD FRACP FCICM FAHMS
Monash University Director of the ANZIC-RC
Professor Cooper is Director of the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC); Director of the NHMRC Centre of Research Excellence for Patient Blood Management in Critical Illness and Trauma (Blood-CRE); Head of the Critical Care Division in the School of Public Health and Preventive Medicine, all at Monash University; and Senior Specialist in Intensive Care and Interim Director of the Department of Intensive Care at The Alfred Hospital, Melbourne. In 2017, he was awarded an Officer of the Order of Australia (AO) for distinguished service to intensive care medicine in the field of traumatic brain injury as a clinician, and to medical education as an academic, researcher and author. He is a National Health and Medical Research Council (NHMRC) Practitioner Fellow, full Professor of Intensive Care Medicine at Monash University and Hon. Professorial Fellow in the Critical Care and Trauma Division at The George Institute for Global Health, University of Sydney. He has published more than 250 journal papers including 17 in New England Journal of Medicine (NEJM), Lancet, Journal of the American Medical Association (JAMA) and Annals of Internal Medicine. He has been a Principal or Co-investigator on peer reviewed research grants exceeding $53 million including 24 NHMRC grants. Research foci include randomised clinical trials in traumatic brain injury, sepsis, acute lung injury, resuscitation fluids, and blood transfusion.
Professor Rinaldo Bellomo MBBS MD FRACP FCICM FAHMS
Monash University Co-Director of the ANZIC-RC, and College of Intensive Care Medicine (CICM) Representative
Rinaldo Bellomo is a Professor of Intensive Care Medicine, University of Melbourne, Melbourne, Australia; Honorary Professor, Faculty of Medicine, Monash University, Melbourne Australia; Honorary Professorial Fellow, Faculty of Medicine, The University of Sydney, Sydney, Australia; Honorary Professorial Fellow, The George Institute, Sydney, Australia; Honorary Fellow, Florey Institute of Physiology, Melbourne, Australia; Honorary Professor, Faculty of Medicine, Nanjing University, Nanjing, China; and Visiting Professor, Università Vita-Salute San Raffaele, Milan, Italy.
Professor Bellomo is the Director of Intensive Care Research and Staff Specialist in Intensive Care at Austin Health. He is Co-Director of the Australian and New Zealand Intensive Care Research Centre (ANZIC-RC) - a methods centre (established with a National Health and Medical Research Council (NHMRC) Enabling Grant) for investigator-initiated clinical research that supports >15 staff, >14 PhD candidates, and research programs in traumatic brain injury, sepsis, transfusion, acute lung injury, nutrition and health economics. He is a NHMRC Practitioner Fellow and was Foundation Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG).
For three years in a row (2014-2016), Professor Bellomo has been named one of the world's most influential scientific minds of our time. Thomson Reuters published "The world's most influential scientific minds" list based on its analysis of data over the previous 11 years using Web of Science and InCites platforms to determine which researchers have produced work that is most frequently acknowledged by peers. Prof Bellomo is one of the researchers identified as "influencing the future direction of their field, and of the world", "on the cutting edge of their field" and "publishing work that their peers recognize as vital to the advancement of their science". He is also the recipient of a NHMRC Achievement Award and an Austin Health Distinguished Scientist Award.
In 2015, Professor Bellomo became the first ANZ biomedical researcher to have more than 1,000 papers in Scopus. He has also written more than 152 book chapters and edited 13 books in the field of intensive care medicine. As at December 2016 he had an h index of 96 (Scopus) and total lifetime citations of >46,000; and a yearly citation rate over the past 5 years of >2,500. He is the Editor-in-Chief of the journal Critical Care and Resuscitation.
Professor Bellomo has been Chief Investigator in many successful grant applications. Over the past 10 years, he has been heavily involved in the design, execution, supervision and publication of several large randomised controlled trials published in The Lancet and the New England Journal of Medicine (NEJM) for >20,000 intensive care unit (ICU) patients randomised.
Professor Alistair Nichol BA (Hons) MB BCh BAO (Hons) DipMan FCARCSI FJFICMI FCICM PhDProfessor of Intensive Care Medicine, ANZIC-RC
Alistair is a Professor of Intensive Care Medicine in the School of Public Health and Preventive Medicine, Monash University, and an honorary intensivist in The Alfred Hospital, Melbourne. Following completion of a PhD at University College Dublin, Alistair commenced with the ANZIC-RC in 2007 and has worked on a number of its large multi-centre randomised controlled trials. He is actively involved with the POLAR-RCT (Prophylactic hypOthermia trail to Lessen trAumatic bRain injury Randomised Control Trial) and the PHARLAP studies. He was also a Chief Investigator on the now completed EPO-TBI (Erythropoietin in Traumatic Brain Injury) Study. His areas of interest include traumatic brain injury (TBI), acute respiratory distress syndrome (ARDS) and mechanical ventilation. Alistair has completed over 10 years of training in Anaesthesia, Intensive Care and Pain Medicine. He was awarded the Fellowship of the College of Anaesthetists, Royal College of Surgeons Ireland (FCARCSI) in 2002, and the Fellowship of the College of Intensive Care Medicine Australia and New Zealand (FCICM) in 2010. Alistair was also awarded a Victorian Neurotrauma Initiative (VNI) Early Career Practitioner Fellowship.
Associate Professor Carol Hodgson PhD FACP
Co-Deputy Director, ANZIC-RC
Associate Professor Hodgson is Deputy Director of the Australian and New Zealand Intensive Care Research Centre in the Department of Epidemiology and Preventive Medicine at Monash University. She leads international trials in mechanical ventilation (PHARLAP) and early mobilisation (TEAM) in ICU. She specialises in long term functional outcomes following ICU and organ support, including ECMO. She is a senior physiotherapist in ICU at the Alfred Hospital and is passionate about multidisciplinary research to improve patient recovery.
Associate Professor Andrew Udy BHB MB ChB PGCert(AME) PhD FCICM
Co-Deputy Director, ANZIC-RC
A/Professor Andrew Udy is Co-Deputy Director of the Australian and New Zealand Intensive Care Research Centre, Monash University, and a full-time intensive care clinician and researcher at The Alfred ICU, Melbourne. He completed his undergraduate medical education at the University of Auckland, followed by ICU training in New Zealand, the United Kingdom and Australia. After award of Fellowship, Andrew worked as a consultant for many years in Queensland, while also completing a PhD in antibiotic pharmacokinetics. His major academic interests include optimised drug prescribing in the critically ill, haemodynamic management in severe sepsis, acute kidney injury and renal replacement therapy, management of subarachnoid haemorrhage, and critical care nutrition. Andrew is involved in critical care research internationally as the Victorian representative on the ANZICS Clinical Trials Group (CTG) Committee. He is also a keen educator; instructing on BASIC, ALS, ECMO and EMST courses, and is Deputy Chair of the Victorian Regional Committee (VRC), College of Intensive Care Medicine.
Professor John McNeil
Head, Monash University Department of Epidemiology and Preventive Medicine
Professor McNeil is the Head of the Department of Epidemiology and Preventive Medicine at Monash University. He graduated in medicine from the University of Adelaide in 1971 and undertook his medical specialist training at the Royal Adelaide and Austin Hospitals. He subsequently completed his PhD in clinical pharmacology at the University of Melbourne and an MSc in epidemiology at the University of London. After spending ten years in Clinical Pharmacology at the Austin Hospital he was appointed to the Head of the Department of Social and Preventive Medicine (later renamed Epidemiology and Preventive Medicine) at Monash in 1986. His principal interests include cardiovascular epidemiology, drug safety and toxicology. He retains a clinical involvement as a vascular physician on the Vascular Medicine Unit at the Monash Medical Centre.
Dr Marc ZiegenfussPresident, Australian and New Zealand Intensive Care Society (ANZICS)
Dr Marc Ziegenfuss is the current President of the ANZICS.
Clinical Associate Professor Craig FrenchChair, Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG)
Associate Professor Craig French is a specialist Intensive Care Physician and Anaesthetist. He is the Director of Intensive Care at Western Health, Melbourne, Australia; a Clinical Associate Professor of the University of Melbourne; and the Chair of the ANZICS Clinical Trials Group. His primary interests are multicentre clinical research, clinical ethics, and guideline development.
Professor David Pilcher MBBS MRCP FCICM FRACP
Chair, Australian and New Zealand Intensive Care Society Centre for Outcome and Resource Evaluation (ANZICS-CORE)
Professor Dave Pilcher has worked as an Intensive Care Specialist at The Alfred Hospital in Melbourne since 2006. He trained in respiratory and general medicine in the United Kingdom before coming to Australia to complete his Intensive Care fellowship in 2002. Professor Pilcher is Director of the ANZICS Adult Patient Database and Chair of the ANZICS-CORE. He holds an Intensive Care Practitioner fellowship with Monash University. His research interests include organ donation, lung transplantation and the epidemiology of intensive care unit outcomes.
Professor Steve Webb MBBS MPH PhD FRACP FCICM FAHMS
Representative, International Forum for Acute Care Trialists (InFACT)
Professor Steve Webb is a Senior Staff Specialist in Intensive Care Medicine at Royal Perth Hospital and a Professor of Critical Care Research in School of Public Health and Preventive Medicine at Monash University. He also holds adjunct Professorial appointments at the University of Western Australia and The George Institute for Global Health.
Professor Webb is a trialist who designs and conducts clinical trials that provide definitive guidance on optimal management for patients with various forms of critical illness. He is a recipient of more than $80M in research funding and has published more than 140 original journal articles including manuscripts in the NEJM (4), JAMA (1), Lancet (2), and BMJ (1).
He is a past-Chair of the ANZICS Clinical Trials Group. He is the Vice-Chair of the International Forum of Acute Care Trialists and a member of the Executive of the International Severe Acute Respiratory Illness Consortium. He is a founding Director of the Australian Clinical Trials Alliance, a foundation Fellow and a member of Council of the Australian Academy of Health and Medical Sciences, and a member of the NHMRC Health Translation Advisory Committee.
His clinical research interests include pandemic preparedness, pneumonia, the long-term consequences of and recovery after critical illness, resuscitation and treatment of patients with septic shock, management of traumatic brain injury, pathogenesis of septic shock, antimicrobial therapy, acute kidney injury, sedation and prevention of delirium, and choice of intravenous fluids in critically ill patients. He is a lead investigator of SPRINT-SARI (Short Period Incidence Study of Severe Acute Respiratory Infection) and REMAP-CAP (Randomised, Embedded, Multifactorial, Adaptive, Platform Trial of Community Acquired Pneumonia). He has particular interest in novel and more efficient trial methods including Platform Trials using Bayesian statistical methods and cluster-crossover trials as well as the interface between clinical trials and healthcare policy.
Dr Colin McArthur
Representative of the New Zealand intensive care research community
Dr Colin McArthur is the Immediate Past Chair of the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG). He is Clinical Director, Department of Critical Care Medicine, Auckland City Hospital; Medical Advisor - Quality & Safety, Auckland District Health Board; and Honorary Clinical Lecturer, Department of Surgery, University of Auckland. He trained in medicine in Auckland and is a Fellow of the College of Intensive Care Medicine (FCICM) and a Fellow of the Australian and New Zealand College of Anaesthetists (FANZCA). He has been an investigator in >30 investigator-initiated studies (and also >15 commercial studies) and an author of >60 publications, mostly multi-centre clinical intensive care research. Since 2001, he has been on the management and/or writing committee of 11 NHMRC or HRCNZ-funded studies, six of which have been completed and published in the New England Journal of Medicine and five are on-going. He is an investigator on several current ANZIC-RC studies including the EPO-TBI, POLAR and SPICE studies. He was also an investigator on the ANZIC-RC's now completed ARISE, INFINITE, and STATINS studies. His interests include research methodology and ethics, traumatic brain injury, sepsis, nutrition, and severe influenza.
Dr Shay McGuinnessRepresentative of the New Zealand intensive care research community
Dr Shay McGuinness is Director of Research at the Cardiothoracic and Vascular Intensive Care Unit (CVICU), Auckland City Hospital, New Zealand, and Clinical Director of the Air Ambulance Service, Auckland District Health Board. Dr McGuinness is the New Zealand representative on the Australian and New Zealand Intensive Care Society Clinical Trials Group (ANZICS-CTG) Executive and is the Chair of the ANZICS-CTG Capacity Working Group Sub-committee. Dr McGuinness trained at medicine and surgery in Sheffield, United Kingdom. He has published more than 25 journal papers including articles in New England Journal of Medicine (NEJM) and Journal of the American Medical Association (JAMA). He has been a Principal or Co-investigator on peer reviewed research grants exceeding (NZ)$2.9 million including 5 NZHRC grants. His research interests include randomised clinical trials in non-invasive ventilation and renal failure. Dr McGuinness is a member of the Management Committees of the ANZIC-RC's PHARLAP-RCT and Supplemental PN trials.
Associate Professor Erica Wood MBBS FRACP FRCPA
Representative from the Transfusion Research Unit, Department of Epidemiology and Preventive Medicine (DEPM)
Associate Professor Wood is a Transfusion Medicine Specialist, and Head of the Transfusion Research Unit at the DEPM. Dr Wood works as a Consultant Haematologist at Southern Health and holds Honorary Consultant Haematologist appointments at The Royal Melbourne Hospital and Peter MacCallum Cancer Centre. Dr Wood is a member of the World Health Organization's Expert Advisory Panel on Transfusion Medicine, and has served as a WHO regional advisor in blood safety. She is the current President of the Australian and New Zealand Society of Blood Transfusion, a member of the International Society of Blood Transfusion Board of Directors, and its working parties on haemovigilance and transfusion-transmissible diseases, and a member of the Board of the International Haemovigilance Network. Dr Wood is a member of the executive and advisory committees of the Blood Matters transfusion practice improvement collaborative (a partnership between the Victorian Department of Health and the Blood Service) and chair of its Serious Transfusion Incident Reporting (STIR) regional haemovigilance program. She is actively involved in teaching, currently serving as Chief Examiner in Haematology for the Royal College of Pathologists of Australasia, and on the RACP/RCPA Haematology Joint Specialist Advisory Committee. Her research projects include: the Transfusion Outcomes Research Collaborative (http://www.torc.org.au) and Mi-iron - Moderately Increased Iron - is Reducing Iron Overload Necessary? (http://clinicaltrials.gov/ct2/show/NCT01631708). Dr Wood is a member of the Blood Matters program team: http://www.health.vic.gov.au/bloodmatters.
Mr Peter Gallagher
Representative from the community
Mr Peter Gallagher is the community representative on the ANZIC-RC Advisory Board. He consults on international trade and public policy to firms, to governments in Australia and around the world and to international organisations. Mr Gallagher works at the interface between governments and private interests trying, among other things, to improve the use of information services in support of economic development strategies. His career has included appointments in the diplomatic service, the University of Melbourne Graduate Business School, a national food industry organisation and as a director of an e-commerce company. He has qualifications in public law, philosophy and economics.
Past Advisory Board Members
The ANZIC-RC would like to thank all of its past Advisory Board Members for their valuable contribution. Past ANZIC-RC Advisory Board Members include:
- Professor John Myburgh
- Dr Peter Hicks
- Associate Professor Sandra Peake
- Professor Simon Finfer
- Professor Bala Venkatesh
- Dr Tim Sutton
- Associate Professor Graeme Hart
- Associate Professor Michael O'Leary
- Associate Professor Robert Boots
- Associate Professor Mary White
- Associate Professor Dianne Stephens
- Associate Professor Andrew Turner
Terms of Reference
The ANZIC-RC is governed by its Terms of Reference (PDF 1.24MB).